| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,960 |
4,753 |
$731K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,894 |
4,621 |
$689K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,567 |
1,517 |
$307K |
| 99215 |
Prolong outpt/office vis |
2,026 |
1,931 |
$289K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,784 |
1,765 |
$274K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,757 |
1,752 |
$242K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,155 |
2,024 |
$177K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,216 |
1,212 |
$148K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,038 |
894 |
$127K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,652 |
1,530 |
$69K |
| 99205 |
Prolong outpt/office vis |
506 |
504 |
$66K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
361 |
353 |
$65K |
| 92567 |
|
1,012 |
1,002 |
$58K |
| 76770 |
|
303 |
299 |
$53K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
241 |
237 |
$44K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
170 |
166 |
$37K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
139 |
108 |
$35K |
| 92015 |
Determination of refractive state |
815 |
815 |
$35K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
89 |
88 |
$31K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,190 |
1,092 |
$28K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
108 |
106 |
$27K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
390 |
383 |
$18K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
119 |
109 |
$15K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
142 |
142 |
$14K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,078 |
1,815 |
$13K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
36 |
36 |
$11K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
105 |
46 |
$11K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
81 |
81 |
$10K |
| 93325 |
|
68 |
66 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
981 |
960 |
$9K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
14 |
14 |
$9K |
| 0002A |
|
159 |
159 |
$7K |
| 0001A |
|
157 |
157 |
$7K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
942 |
899 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
15 |
13 |
$6K |
| 92060 |
|
165 |
165 |
$6K |
| G0378 |
Hospital observation service, per hour |
64 |
28 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
444 |
441 |
$6K |
| 92587 |
|
25 |
25 |
$5K |
| 83735 |
|
1,072 |
887 |
$5K |
| 0071A |
|
131 |
131 |
$5K |
| 0072A |
|
123 |
123 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
136 |
133 |
$5K |
| 91307 |
|
261 |
245 |
$4K |
| 97803 |
|
75 |
72 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
75 |
73 |
$4K |
| 86140 |
|
926 |
823 |
$4K |
| 92557 |
|
26 |
26 |
$4K |
| 80051 |
|
449 |
426 |
$3K |
| 97010 |
|
38 |
18 |
$3K |
| 0004A |
|
82 |
82 |
$3K |
| 85027 |
|
638 |
596 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
474 |
367 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
14 |
14 |
$3K |
| 72081 |
|
399 |
392 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
875 |
815 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
141 |
138 |
$3K |
| 84439 |
|
306 |
304 |
$2K |
| 85652 |
|
859 |
821 |
$2K |
| 83540 |
|
338 |
330 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$2K |
| 82728 |
|
169 |
164 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
83 |
60 |
$2K |
| 83690 |
|
283 |
267 |
$1K |
| 82247 |
|
1,134 |
1,005 |
$1K |
| 84466 |
|
149 |
149 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
25 |
23 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
77 |
76 |
$1K |
| 82784 |
|
130 |
129 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
150 |
149 |
$903.72 |
| 73630 |
|
28 |
27 |
$871.66 |
| 92579 |
|
138 |
138 |
$854.56 |
| 83516 |
|
78 |
78 |
$810.75 |
| 82248 |
|
1,271 |
1,130 |
$787.50 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
23 |
23 |
$736.23 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
23 |
23 |
$736.23 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
31 |
30 |
$696.85 |
| 72100 |
|
13 |
13 |
$689.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,903 |
1,805 |
$672.09 |
| 82565 |
|
697 |
662 |
$671.04 |
| 85730 |
|
170 |
152 |
$652.50 |
| 82040 |
|
133 |
127 |
$629.62 |
| 86850 |
|
99 |
91 |
$628.14 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
141 |
122 |
$623.09 |
| 92083 |
|
12 |
12 |
$605.16 |
| 80061 |
Lipid panel |
64 |
64 |
$604.96 |
| 73610 |
|
54 |
51 |
$598.19 |
| 90686 |
|
19 |
19 |
$569.33 |
| 82150 |
|
124 |
118 |
$561.45 |
| 80053 |
Comprehensive metabolic panel |
44 |
26 |
$488.58 |
| 84450 |
|
1,303 |
1,168 |
$446.57 |
| 92133 |
|
12 |
12 |
$437.06 |
| 85610 |
|
173 |
154 |
$429.75 |
| 83970 |
|
13 |
13 |
$414.15 |
| 84460 |
|
1,303 |
1,170 |
$411.72 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
251 |
249 |
$393.55 |
| 84702 |
|
27 |
26 |
$370.98 |
| 83615 |
|
1,021 |
869 |
$360.41 |
| 85007 |
|
188 |
171 |
$344.09 |
| 84156 |
|
108 |
106 |
$322.45 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
19 |
17 |
$285.30 |
| 73130 |
|
13 |
13 |
$275.60 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$263.64 |
| 86900 |
|
99 |
91 |
$234.78 |
| 86901 |
|
99 |
91 |
$234.78 |
| 73522 |
|
172 |
169 |
$216.45 |
| 84075 |
|
1,133 |
1,005 |
$215.85 |
| 81001 |
|
86 |
83 |
$214.66 |
| 80069 |
|
27 |
27 |
$194.12 |
| 86803 |
|
14 |
14 |
$182.14 |
| 73560 |
|
13 |
13 |
$169.67 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
28 |
25 |
$169.28 |
| 84484 |
|
16 |
14 |
$156.57 |
| 87340 |
|
15 |
15 |
$141.30 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
39 |
35 |
$139.92 |
| 84520 |
|
694 |
657 |
$113.64 |
| 82550 |
|
211 |
203 |
$113.29 |
| 85046 |
|
27 |
26 |
$104.56 |
| 82043 |
|
20 |
20 |
$95.04 |
| 81003 |
|
52 |
52 |
$88.15 |
| 84100 |
|
829 |
662 |
$82.90 |
| 82570 |
|
20 |
20 |
$75.52 |
| 84703 |
|
15 |
15 |
$75.46 |
| 81002 |
|
14 |
13 |
$33.41 |
| 82947 |
|
363 |
349 |
$32.82 |
| 91300 |
|
328 |
302 |
$0.00 |
| 82310 |
|
19 |
16 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
21 |
21 |
$0.00 |
| 84550 |
|
58 |
36 |
$0.00 |
| 94760 |
|
1,111 |
1,092 |
$0.00 |
| 88342 |
|
66 |
65 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
23 |
17 |
$0.00 |
| 93320 |
|
37 |
36 |
$0.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
71 |
31 |
$0.00 |
| 88304 |
|
25 |
25 |
$0.00 |